| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.30B | 46.65B | 38.82B | 42.16B | 39.19B | 21.99B |
| Gross Profit | 26.68B | 20.35B | 14.40B | 16.85B | 18.06B | 8.29B |
| EBITDA | 17.92B | 12.48B | 8.00B | 10.56B | 13.45B | 5.05B |
| Net Income | 10.63B | 7.00B | 5.23B | 6.02B | 8.04B | 3.75B |
Balance Sheet | ||||||
| Total Assets | 110.12B | 101.25B | 60.02B | 54.81B | 52.98B | 45.21B |
| Cash, Cash Equivalents and Short-Term Investments | 22.76B | 12.57B | 13.26B | 7.97B | 7.33B | 3.12B |
| Total Debt | 26.81B | 28.61B | 13.66B | 14.07B | 15.81B | 17.14B |
| Total Liabilities | 39.04B | 37.32B | 20.08B | 19.71B | 21.90B | 21.99B |
| Stockholders Equity | 69.99B | 62.86B | 38.89B | 34.10B | 30.04B | 22.21B |
Cash Flow | ||||||
| Free Cash Flow | 10.35B | 3.95B | 4.87B | 4.85B | 6.35B | -1.15B |
| Operating Cash Flow | 12.73B | 8.86B | 7.52B | 7.01B | 9.17B | 1.89B |
| Investing Cash Flow | -9.35B | -21.32B | -4.34B | -4.31B | -4.01B | -1.86B |
| Financing Cash Flow | -3.57B | 12.00B | -2.22B | -4.79B | -3.31B | -696.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ₹26.61B | 8.35 | ― | 1.65% | 21.44% | -46.24% | |
74 Outperform | ₹191.27B | 28.50 | ― | 0.39% | -0.96% | -11.90% | |
68 Neutral | ₹70.77B | 15.33 | ― | 1.05% | -6.18% | -23.70% | |
68 Neutral | ₹80.92B | 7.74 | ― | 1.82% | 0.81% | -7.11% | |
66 Neutral | ₹229.66B | 29.89 | ― | 0.77% | 18.36% | 13.94% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ₹186.18B | 24.09 | ― | 0.28% | 46.66% | 75.53% |